Anixa Biosciences (ANIX) Net Shares Issued and Repurchased (2013 - 2025)

Anixa Biosciences (ANIX) has reported Net Shares Issued and Repurchased for 8 consecutive years, with $1.4 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Net Shares Issued and Repurchased rose 1.77% year-over-year to $1.4 million; the trailing twelve-month figure through Oct 2025 stood at $1.4 million (up 1.77% YoY), and the FY2025 full-year result was $1.4 million, up 1.77% from the prior year.
• Net Shares Issued and Repurchased grew to $1.4 million in Q4 2025 per ANIX's latest filing, from $75000.0 in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $4.5 million in Q4 2021 and bottomed at $15000.0 in Q2 2024.
• Historically, Net Shares Issued and Repurchased has averaged $1.2 million across 5 years, with a median of $1.4 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Net Shares Issued and Repurchased sank 97.35% in 2022, then soared 4916.67% in 2023.
• Over 5 years, Net Shares Issued and Repurchased stood at $4.5 million in 2021, then slumped by 68.15% to $1.4 million in 2022, then grew by 14.69% to $1.6 million in 2023, then retreated by 13.72% to $1.4 million in 2024, then climbed by 1.77% to $1.4 million in 2025.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $1.4 million, $75000.0, and $1.4 million for Q4 2025, Q3 2025, and Q1 2025 respectively.